Cartesian Therapeutics, Inc.

Direct answer

Cartesian Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RNAC.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized...

Can you invest in Cartesian Therapeutics, Inc.?

Yes. Cartesian Therapeutics, Inc. trades publicly on NASDAQ as RNAC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cartesian Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.